生物制药公司TG Therapeutics(TGTX.US)股价大跌 Q1盈利不及预期

智通财经
05 May

智通财经APP获悉,周一美股盘初,截至发稿,生物制药公司TG Therapeutics(TGTX.US)股价大跌近15%。消息面上,TG Therapeutics公布的2025年第一季度财报显示,Q1营收为1.21亿美元,同比增长90.4%,较分析师预期高300万美元;GAAP每股收益为0.03美元,较分析师预期低0.14美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10